Delivery Order SPE2DB22D3016-SPE2DB25FAPL3

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,411.48 and covers the delivery of 4563249462 - METHIMAZOLE 5 MG TABLET 90S. It is a Firm Fixed Price Delivery Order contract with a performance period through January 8, 2024. This award is not designated with a set-aside requirement. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FABN9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,291.53, is for the delivery of 4562614169 - Methimazole 5 mg Tablets, 180 count, and has an ultimate completion date of October 27, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,567,111,751 Methimazole 10 mg tablets in 100-count bottles. The contract has a ceiling value of $3,943.13 and a completion date of February 3, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,016,240 units of Methimazole 10 mg tablets. The firm-fixed-price delivery order contract, valued at $1,178.78, has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $2,407.21, was issued by the Defense Logistics Agency's (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the delivery of 4562614647 METHIMAZOLE 10 MG TABLET 180S, with an ultimate completion date of October 27, 2023. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The award, valued at $1,943.30, is for the delivery of Methimazole 10 mg tablets over a period ending on August 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,031.00, is a Firm Fixed Price Delivery Order for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of November 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Methimazole 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $2,185.98, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNZ12, is for the delivery of Methimazole 5 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,200.05 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on January 12, 2024, with a completion date of January 16, 2024. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,190.46, is for the delivery of 90 tablets of the drug Methimazole 5 mg. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAPL3
    Delivery Order

This federal contract award SPE2DB22D3016|SPE2DB25FAPL3, valued at $2,992.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567379504 - METHIMAZOLE 10 MG TABLET 100S, a pharmaceutical product, with a completion date of February 26, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:43 AM